|
Neuraxial Labor Analgesia and Offspring Neurodevelopment
RECRUITINGSponsored by Dong-Xin Wang
Actively Recruiting
SponsorDong-Xin Wang
Started2022-10-14
Est. completion2026-12
Eligibility
Age18 Years – 35 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04964206
Summary
How perinatal factors affect the long-term development of children has always been an issue of much concern. This study is designed to explore the potential impact of maternal neuraxial labor analgesia exposure on offspring neurodevelopment.
Eligibility
Age: 18 Years – 35 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: 1. Primiparae between 18 and 35 years of age with term single cephalic pregnancy; 2. Undergo regular prenatal examination in the study centers; 3. Preparing to deliver vaginally. Exclusion Criteria: 1. History of psychiatric diseases (indicate those that are diagnosed before or during pregnancy by psychiatrists); 2. History of diseases involving the hypothalamic-pituitary-adrenal axis; 3. Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy. 4. Presence of contraindications to vaginal delivery; 5. Other reasons that are considered unsuitable for study participation.
Conditions6
DepressionLabor PainMaternal Anesthesia and Analgesia Affecting Fetus or NewbornNeurodevelopmental DelayOffspring, AdultPostpartum Depression
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorDong-Xin Wang
Started2022-10-14
Est. completion2026-12
Eligibility
Age18 Years – 35 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04964206